Abstract
The literature provides ample evidence that mammary carcinogenesis is a nonrandom event influenced by such risk factors as ethnic group, family history, age, parity and, perhaps, nutritional factors (Lilienfeld 1963; Macklin 1959; Vakil and Morgan 1973). It is, therefore, not surprising that patients who develop a cancer in one breast are at a greatly increased risk of developing a second primary breast cancer (Harrington 1946; McCredie et al. 1975). In response to such observations some have gone so far as to recommend prophylactic removal of the “second” breast (Leis 1979). Certainly it is clinically and conceptually important to take note of the increased risk of second breast cancers. However, it may be of even greater importance to consider the paradox that among patients who have the necessary and sufficient requirements to develop breast cancer, only a small minority will develop a primary cancer in the second breast. This is all the more surprising in view of the similarity in microscopic structure, mammographic patterns, and physical proximity of the two breasts. Moreover, the relatively low incidence of second primaries persists regardless of the age at diagnosis of the first lesion, family history, parity, or any constellation of known risk factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akiyoski T, Nakamura Y, Kawaguchi M, Tsuji H (1978) Cellular hypersensitivity to autologous tumor extracts in patients with breast carcinoma. Jpn J Surg 8: 236–241
Black MM (1965) Reactivity of the lymphoreticuloendothelial system in human cancer. Prog Clin Cancer 1: 26–49
Black MM (1972) Cellular and biologic manifestations of immunogenicity in precancerous mastopathy. Natl Cancer Inst Monogr 35: 73–82
Black MM (1973) Human breast cancer. A model for cancer immunology. Isr J Med Sci 9: 284–299
Black MM (1975) Immunology of breast cancer: Clinical implications. Prog Clin Cancer 6: 115–138
Black MM (1976) Structural, antigenic and biologic characteristics of precancerous mastopathy. Cancer Res 36: 2596–2604
Black MM (1977) Immunopathology of breast cancer. Pathobiol Ann 7: 213–230
Black MM, Chabon AB (1969) In situ carcinoma of the breast. Pathol Annu 4: 185–210
Black MM, Kwon CS (1978) Prognostic factors. In: Gallager HS, Leis HP, Jr, Snyderman RK, Urban JA (eds) The breast. Mosby St. Louis, pp 297–319
Black MM, Kwon CS (1980) Precancerous mastopathie: Structural and biological considerations. Pathol Res Pract 116: 491–514
Black MM, Leis HP Jr (1970) Human breast carcinoma. III. Cellular responses to autologous breast cancer: Skin window procedure. NY State J Med 70: 2583–2589
Black MM, Leis HP Jr (1971) Cellular responses to autologous breast cancer tissue: Correlation with stage and lymphoreticuloendothelial reactivity. Cancer 28: 263–273
Black MM, Leis HP Jr (1973) Cellular responses to autologous breast cancer tissue: Sequential observations. Cancer 32: 384–389
Black MM, Speer FD (1959) Immunology of cancer. Surg Gynecol Obstet 109: 105–116
Black MM, Zachrau RE (1978) Immunotherapy of breast cancer? In: Gallager HS, Leis HP Jr, nyderman RK, Urban JA (eds). The breast. Mosby St. Louis, pp 393–408
Black MM, Zachrau RE (1979) Antitumor immunity in breast cancer patients: Biologic and therapeutic implications. J Reprod Med 23: 21–32
Black MM, Speer FD, Opler SR (1956) Structural representations of the tumor-host relationships in mammary carcinoma, biologic and prognostic significance. Am J Clin Pathol 26: 250–265
Black MM, Cutler SJ, Barclay THC (1972) Post biopsy breast carcinoma: A natural experiment in cancer immunology. Cancer 29: 61–65
Black MM, Leis HP Jr, Shore B, Zachrau RE (1974a) Cellular hypersensitivity to breast cancer. Assessment by a leukocyte migration procedure. Cancer 33: 952–958
Black MM, Moore DH, Shore B, Zachrau RE, Leis HP Jr (1974b) Effect of murine milk samples and human breast tissues on human leukocyte migration indices. Cancer Res 34: 1054–1060
Black MM, Zachrau RE, Shore B, Moore DH, Leis HP Jr (1975a) Prognostically favorable immunogens of human breast cancer tissue: Antigenic similarity to murine mammary tumor virus. Cancer 35: 121–128
Black MM, Barclay THC, Hankey BF (1975b) Prognosis in breast cancer utilizing histologic characteristics, of the primary tumor. Cancer 36: 2048–2055
Black MM, Zachrau RE, Shore B, Dion AS, Leis HP Jr (1978) Cellular immunity to autologous breast cancer and RHI-murine mammary tumor virus preparations. Cancer Res 38: 2068–2076
Black MM, Zachrau RE, Dion AS, Katz M (1983a) Vitamin A stimulation of specific cell-mediated immunity in breast cancer patients. Fed Proc 42: 1197
Black MM, Zachrau RE, Dion AS, Katz M (1983b) Stimulation of prognostically favorable cellmediates immunity of breast cancer patients by high dose vitamin A and vitamin E. In: Prasad KN (ed) Vitamins, Nutrition and Cancer. Karger Basel, 134–146
Cannon GB, Dean JH, Herberman RB, Keets M. Alford C (1981) Lymphoproliferative responses to autologous tumor extracts as prognostic indicators in patients with resected breast cancer. Int J Cancer 27: 131–138
Harrington SW (1946) Survival rates of radical mastectomy for unilateral and bilateral carcinoma of the breast. Surgery 19: 154–166
Herberman RB (1983) Counterpoint: Animal tumor models and their relevance to human tumor immunology. J Biol Resp Modif 2:39–46, 217–226
Hewitt HB (1982) Animal tumor models and their relevance to human tumor immunology. J Biol Resp Modif 1: 107–119
Leis HP Jr (1979) Selective and reconstructive surgical procedures for carcinoma of the breast. Surg Gynecol Obstet 148: 27–32
Lilienfeld AM (1963) The epidemiology of breast cancer. Cancer Res 23: 1503–1513
Macklin MT (1959) Comparison of the number of breast-cancer deaths observed in relatives of breast-cancer patients, and the number expected on the basis of mortality rates. JNCI 22: 927–951
McCredie JA, Inch WR, Anderson M (1975) Consecutive primary carcinomas of the breast. Cancer 35: 1472–1477
Vakil DV, Morgan RW (1973) Etiology of breast cancer. II. Epidemiologic aspects. Can Med Assoc J 109: 201–206
Webber BL, Heise H, Neifeld JP, Costa J (1981) Risk of subsequent contralateral breast carcinoma in a population of patients with in situ breast carcinoma. Cancer 47: 2928–2932
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Black, M.M., Zachrau, R.E. (1985). Stepwise Mammary Carcinogenesis: Immunological Considerations. In: Zander, J., Baltzer, J. (eds) Early Breast Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70192-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-70192-4_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70194-8
Online ISBN: 978-3-642-70192-4
eBook Packages: Springer Book Archive